Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Tran

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
Biomedicines|July 27, 2022
Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver TransplantationAudrey Laurain, Isabelle Rubera, Micheline Razzouk-Cadet, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 19, 2021
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic SteatohepatitisCarmelo Luci, Elodie Vieira, Manon Bourinet, et al.
Kidney International Reports|February 19, 2019
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney DiseaseDavid E Bernstein, Albert Tran, Paul Martin, et al.
World Journal of Gastrointestinal Oncology|September 26, 2022
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matchingXavier Adhoute, Marie De Matharel, Laurent Mineur, et al.
European Journal of Gastroenterology & Hepatology|October 19, 2004
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosisArmand Abergel, Claude Darcha, Michèle Chevallier, et al.
Chinese Clinical Oncology|December 22, 2025
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centersLouis Carmarans, Claude Somma, Victoria Ramdour, et al.
European Journal of Gastroenterology & Hepatology|November 20, 2002
Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitisGeoffroy Vanbiervliet, Christian Rakotoarisoa, Jerôme Filippi, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High Fat, High Fructose, High Cholesterol Diet Mouse ModelPhoebe Ohene-Marfo, Hoang Van M Nguyen, Sabira Mohammed, et al.
Hepatology (Baltimore, Md.)|February 20, 2018
Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in miceCynthia Lebeaupin, Déborah Vallée, Déborah Rousseau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 31, 2007
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trialLaetitia Fartoux, Françoise Degos, Christian Trépo, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Biomedicines|July 27, 2022
Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver TransplantationAudrey Laurain, Isabelle Rubera, Micheline Razzouk-Cadet, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 19, 2021
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic SteatohepatitisCarmelo Luci, Elodie Vieira, Manon Bourinet, et al.
Kidney International Reports|February 19, 2019
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney DiseaseDavid E Bernstein, Albert Tran, Paul Martin, et al.
World Journal of Gastrointestinal Oncology|September 26, 2022
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matchingXavier Adhoute, Marie De Matharel, Laurent Mineur, et al.
European Journal of Gastroenterology & Hepatology|October 19, 2004
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosisArmand Abergel, Claude Darcha, Michèle Chevallier, et al.
Chinese Clinical Oncology|December 22, 2025
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centersLouis Carmarans, Claude Somma, Victoria Ramdour, et al.
European Journal of Gastroenterology & Hepatology|November 20, 2002
Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitisGeoffroy Vanbiervliet, Christian Rakotoarisoa, Jerôme Filippi, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High Fat, High Fructose, High Cholesterol Diet Mouse ModelPhoebe Ohene-Marfo, Hoang Van M Nguyen, Sabira Mohammed, et al.
Hepatology (Baltimore, Md.)|February 20, 2018
Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in miceCynthia Lebeaupin, Déborah Vallée, Déborah Rousseau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 31, 2007
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trialLaetitia Fartoux, Françoise Degos, Christian Trépo, et al.
Pageof 19